| Date Filed | Type | Description |
| 01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/07/2022 |
4
| Meisner Derek M (Chief Legal Office & Corp Sec) has filed a Form 4 on Acumen Pharmaceuticals, Inc.|
Txns:
| Granted 225,000 options to buy
@ $6.08, valued at
$1.4M
|
|
| 09/07/2022 |
3
| Meisner Derek M (Chief Legal Office & Corp Sec) has filed a Form 3 on Acumen Pharmaceuticals, Inc. |
| 08/19/2022 |
4
| Meisner Derek M (Chief Legal Officer) has filed a Form 4 on X4 Pharmaceuticals, Inc|
Txns:
| Sold 8,334 shares
@ $0 |
|
| 06/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/25/2021 |
4
| Meisner Derek M (General Counsel) has filed a Form 4 on X4 Pharmaceuticals, Inc|
Txns:
| Granted 12,500 shares
@ $0
Sold 4,166 shares
@ $7, valued at
$29.2k
|
|
| 06/17/2021 |
4
| Meisner Derek M (General Counsel) has filed a Form 4 on X4 Pharmaceuticals, Inc|
Txns:
| Granted 12,500 shares
@ $0
Sold 4,166 shares
@ $7.84, valued at
$32.7k
|
|
| 03/25/2021 |
4
| Meisner Derek M (General Counsel) has filed a Form 4 on X4 Pharmaceuticals, Inc|
Txns:
| Granted 47,728 shares
@ $0 |
|
| 08/18/2020 |
4
| Meisner Derek M (General Counsel) has filed a Form 4 on X4 Pharmaceuticals, Inc|
Txns:
| Granted 12,500 shares
@ $0
Granted 12,500 shares
@ $0 |
|
| 11/27/2019 |
4
| Meisner Derek M (General Counsel) has filed a Form 4 on X4 Pharmaceuticals, Inc|
Txns:
| Granted 55,000 options to buy
@ $11.03, valued at
$606.7k
|
|
| 11/06/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/11/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/21/2018 |
4
| Meisner Derek M (SENIOR VP AND GENERAL COUNSEL) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.|
Txns:
| Granted 200,000 options to buy
@ $0.51, valued at
$102k
|
|
| 09/20/2018 |
3
| Meisner Derek M (SENIOR VP AND GENERAL COUNSEL) has filed a Form 3 on GENOCEA BIOSCIENCES, INC. |